MCK Stock: McKesson Corporation Stock Price, Analysis & Insights
Get live mck stock price $810.67, comprehensive McKesson Corporation stock analysis, charts, news, and expert forecast. Real-time mck stock data and investment insights.
Loading chart...
Company Overview
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Company Information
- CEO
- Brian S. Tyler
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 44000
Contact Information
- Website
- https://www.mckesson.com
- Address
- 6555 State Highway 161
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 100.8 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 32.4)
✓ Lower volatility stock (Beta: 0.51) may provide portfolio stability
Business Model & Strategy
McKesson Corporation operates in the Medical - Distribution industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a mid-cap company, McKesson Corporation benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Brian S. Tyler, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Distribution model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
McKesson Corporation competes in the Medical - Distribution within the broader Healthcare. With 100.8 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, McKesson Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating McKesson Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for McKesson Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for McKesson Corporation
- ⚠Investors should consider how McKesson Corporation fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 32.4) requires strong growth to justify
Market Cap
100.84B
P/E Ratio
32.44
Beta
0.51
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 100.84B market capitalization
- Trading Volume: 93.31K shares traded today
- Price Range: 52-week range of $520.20 - $846.32
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for McKesson Corporation
McKesson Corporation (MCK) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 100.84B, the company represents a significant player in its market. The stock is currently trading at $810.67 with a negativedaily change of 0.08%.
The company's 44000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 32.44, beta of 0.51, and 52-week price range from $520.20 to $846.32when evaluating investment opportunities.
Why Invest in McKesson Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Brian S. Tyler
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.